Orange Book product · Generic (ANDA)
METHOCARBAMOL
METHOCARBAMOL
At a glance
Jun 22, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 22, 2017
9 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
METHOCARBAMOL
Strength
1GM/10ML (100MG/ML)
Dosage form
SOLUTION
Route
IM-IV
TE code
AP
Application
ANDA 207496
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHOCARBAMOL
- 2025ATMEKSIBrand (NDA)
NDA 219843 · ROSEMONT PHARMS
- —ROBAXINBrand (NDA)
NDA 011790 · HIKMA
- 2023METHOCARBAMOLGeneric (ANDA)
ANDA 212707 · MIKART
- 2023METHOCARBAMOLGeneric (ANDA)
ANDA 213967 · AUROBINDO PHARMA LTD
- 2022METHOCARBAMOLGeneric (ANDA)
ANDA 215065 · BAXTER HLTHCARE CORP
- 2021METHOCARBAMOLGeneric (ANDA)
ANDA 200958 · BOSTAL
- 2018METHOCARBAMOLGeneric (ANDA)
ANDA 211504 · GLAND
- 2018METHOCARBAMOLGeneric (ANDA)
ANDA 209312 · GRANULES
- 2018METHOCARBAMOLGeneric (ANDA)
ANDA 209331 · FRESENIUS KABI USA
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 206071 · NAVINTA LLC
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 207522 · SOMERSET THERAPS LLC
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 205404 · SAGENT PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
